Common Stock

Common stock

Common stock

Common stock

Common stock

Common stock

Common stock

Common stock

DRIP acquisition exempt from Section 16 reporting being reported voluntarily

500 shares vest on 11/15/2019, 11/15/2020, 11/15/2021 and 11/15/2022

500 shares vest on 11/28/2020, 11/28/2021, 11/28/2022 and 11/28/2023

500 shares vest on 11/20/2021, 11/20/2022, 11/20/2023 and 11/20/2024

500 shares vest on 10/26/2024 and 10/26/2025

500 shares vest on 11/17/2023, 11/17/2024, 11/17/2025 and 11/17/2026

500 shares vest on 11/16/2024, 11/16/2025, 11/16/2026 and 11/16/2027

500 shares vest on 11/15/2025, 11/15/2026, 11/15/2027 and 11/15/2028

500 shares vest on 11/20/2026, 11/20/2027, 11/20/2028 and 11/20/2029

Matt Snyder, by Power of Attorney from Julie A. Brown


Colleen O'Dell - Custodian for Sarah F. O'Dell


The Common Shares of Beneficial Interest were granted to the Reporting Person as long-term incentive compensation and will vest in four annual installments, beginning January 1, 2026.

/s/ Angela M. Whittaker, attorney-in-fact for Benjamin N. Fox


Common Stock, par value $0.0001

This Form 4 relates to a bona fide gift of publicly-traded warrants (the "Warrants") previously distributed to the Rodgers Massey Revocable Living Trust dtd 4/4/11 (the Trust) for which the Reporting Person is a trustee and has voting and dispositive power over the Warrants. The Warrants were distributed by the Issuer on July 21, 2025 at no cost to the Reporting Person, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement dated July 21, 2025 between the Issuer and Computershare Trust Company N.A., as warrant agent (the "Warrant Agreement").

Represents a bona fide gift of 500,000 Warrants from the Trust to a donor advised fund.

The Warrants will expire and cease to be exercisable at 5:00 p.m. New York City time on October 1, 2026 (the Expiration Date). The Expiration Date is subject to automatic acceleration upon satisfaction of the early expiration price condition (as defined in the Warrant Agreement) and subject to the other terms of the Warrant Agreement.

The remaining Warrants are held by the Trust for which the Reporting Person is a trustee and has voting and dispositive power over the Warrants.

/s/ Arthi Chakravarthy, Attorney-in-Fact for Thurman J. Rodgers


Common Stock

Represents adjustment in number of shares relating to award of performance-based restricted stock units previously reported on February 10, 2023, using target number of shares (1,417 shares). The award vested as to 1,004 shares on August 14, 2025, based on the level of achievement of the performance goal.

Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 20% increments on February 11, 2023, 2024, 2025, 2026 and 2027.

/s/ Tony J. VunCannon, Attorney-in-Fact for Megan Pelletier


Common Stock

Common Stock

Common Stock

Represents adjustment in number of shares relating to award of performance-based restricted stock units previously reported on February 10, 2023, using target number of shares (7,891 shares). The award vested as to 5,593 shares on August 14, 2025, based on the level of achievement of the performance goal.

Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule:  20% increments on February 11, 2019, 2020, 2021, 2022 and 2023.

/s/ Tony J. VunCannon, Attorney-in-Fact for Hunter Westbrook


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Represents adjustment in number of shares relating to award of performance-based restricted stock units previously reported on February 10, 2023, using target number of shares (2,181 shares). The award vested as to 1,546 shares on August 14, 2025, based on the level of achievement of the performance goal.

Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 20% increments on February 11, 2017, 2018, 2019, 2020 and 2021.

Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 20% increments on February 11, 2018, 2019, 2020, 2021 and 2022.

Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 20% increments on February 11, 2019, 2020, 2021, 2022 and 2023.

Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 20% increments on February 11, 2022, 2023, 2024, 2025 and 2026.

/s/ Tony J. VunCannon, Attorney-in-Fact for Kristin Y. Powell


Common Stock

Represents adjustment in number of shares relating to award of performance-based restricted stock units previously reported on February 10, 2023, using target number of shares (1,612 shares). The award vested as to 1,142 shares on August 14, 2025, based on the level of achievement of the performance goal.


Common Stock

Each unit represents a contingent right to receive one share of Pitney Bowes common stock.

Vests in three (3) equal annual installments beginning on the anniversary date of the grant, with the first vesting on August 13, 2026.

/s/ Elisabeth Weinberg, as attorney-in-fact for Paul J. Evans


/s/ Christopher L. Fowler, by power of attorney


Shares withheld to pay the reporting person's tax withholding obligation upon vesting of a portion of August 14, 2023 Restricted Stock Unit Award.

/s/Tiffany B. Williams, Attorney-In-Fact for Renee Swan


Includes shares of DTE common stock acquired under the DTE Energy Company Savings and Stock Ownership Plan (the "Plan") as of a Plan statement dated as of August 14, 2025.


Includes 1,698 restricted shares that vest on 2/20/2028, 1,715 restricted shares that vest on 2/22/2027, 1,555 restricted shares that vest on 2/16/2026, and 3,203 shares owned outright.


Common Stock

Common Stock

The price reported within column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $62.88 to $63.23, inclusive. The reporting person undertakes to provide to CAKE Corporation, any security holder of CAKE Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

The price reported within column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $62.85 to $62.97, inclusive. The reporting person undertakes to provide to CAKE Corporation, any security holder of CAKE Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

The price reported within column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.34 to $63.46, inclusive. The reporting person undertakes to provide to CAKE Corporation, any security holder of CAKE Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

Shares of restricted stock subject to forfeiture.

/s/ David M. Gordon by Scarlett May, Attorney-in-Fact


Common Stock

Amount includes 427.769 shares held under dividend reinvestment plans acquired periodically in transactions, which are exempt from Section 16(b).

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.07 to $21.135, inclusive. The reporting person undertakes to
provide to Olin Corporation, any security holder of Olin Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each
separate price within the ranges set forth in this footnote (2) to this Form 4.

The figure represents shares of Olin Common Stock held under the Olin Corporation Retirement Savings Plan, a tax conditioned plan reflecting transactions exempt under Rule 16b-3, as reported by
the RSP Plan Administrator as of August 13, 2025.


/s/ Eric J. Sorenson, Jr., POA for J. Todd Scruggs


/s/ Nathan G. Brower as attorney-in-fact for Jonathan D. Lanoy


The reported price in column 4 is a weighted average purchase price. These shares were disposed of in multiple transactions at prices ranging from $12.50 to $12.61 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth within this footnote.


Common Shares

Common Shares

Includes 604 shares Dr. Ezell acquired under Flotek Industries, Inc. 2012 Employee Stock Purchase plan for the three month period commencing April 1, 2025. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

75% of the options vested on May 16, 2025 and the remaining 25% vested on July 29, 2025.

100% of the options vested on March 7, 2024.


/s/ Marta R. Stewart by her attorney-in-fact, Steven E. Fivel


On December 18, 2024, Horizon Kinetics Asset Management LLC (HKAM) filed an amendment to its Schedule 13D, in which it noted beneficial ownership of 3,578,173 shares and Murray Stahl's direct interest in 7,848 shares and his indirect interest in approximately 156,083 shares. The extent of HKAM's pecuniary interest in the shares beneficially owned is disclosed herein. Mr. Stahl does not exercise investment discretion with respect to the securities of the Issuer.


The	price	reported	is	a	weighted	average	price.	These	shares	were	purchased in	multiple	transactions	at	prices	ranging	from	$10.94	to	$11.01,	inclusive.	The	reporting	person undertakes	to	provide	the Issuer,	any	security	holder	of	the Issuer	or	the	staff	of	the	Securities	and	Exchange	Commission,	upon	request,	full	information	regarding	the	number	of	shares	sold	at each	separate	price	within	the	range	set	forth	in	this	footnote.

The	price	reported	is	a	weighted	average	price.	These	shares	were	purchased in	multiple	transactions	at	prices	ranging	from	$10.98	to	$11.04,	inclusive.	The	reporting	person undertakes	to	provide	the Issuer,	any	security	holder	of	the Issuer	or	the	staff	of	the	Securities	and	Exchange	Commission,	upon	request,	full	information	regarding	the	number	of	shares	sold	at each	separate	price	within	the	range	set	forth	in	this	footnote.

These shares are held in trusts for the benefit of certain immediate family members of the Reporting Person. The Reporting Person is co-trustee of such trusts. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

/s/ Mojirade James, as attorney-in-fact for Gary D. Blackford


All shares sold at an exact price of $77.750000


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Represents shares of common stock of the Issuer received on December 21, 2023, as consideration pursuant to that certain Merger Agreement, dated as of June 27, 2023 (as amended on September 22, 2023 and as may be further amended and/or restated from time to time, the "Merger Agreement"), by and among Airship AI Holdings, Inc., a Delaware corporation (the "Issuer") (formerly known as BYTE Acquisition Corp., a Cayman Island exempted company limited by shares, prior to its domestication as a Delaware corporation), BYTE Merger Sub, Inc., a Washington corporation and a direct, wholly-owned subsidiary of the Issuer, and Airship AI, Inc., a Washington company (formerly known as Airship AI Holdings, Inc., "Airship AI"). The Reporting Person received the reported shares in exchange for shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Airship Kirkland Family Limited Partnership is the record holder of the securities reported herein. Victor Huang is the managing partner of Airship Kirkland Family Limited Partnership and as such has voting and dispositive power over these securities. Mr. Huang disclaims beneficial ownership of the securities held by Airship Kirkland Family Limited Partnership, except to the extent of his pecuniary interest therein.

Represents options to purchase shares of common stock of the Issuer received on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of options to purchase shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Represents stock appreciation rights denominated in shares of common stock of the Issuer received on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of stock appreciation rights denominated in shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Represents warrants to purchase shares of common stock of the Issuer received by the Reporting Person on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of warrants to purchase shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Pursuant to earnout provisions in the Merger Agreement, the holder of such Earnout Rights is entitled to receive shares of common stock of the Issuer upon the occurrence of certain operating performance and share price performance milestones during the applicable earnout periods set forth in the Merger Agreement.

Options vest quarterly over 4 years.

Public Warrant (AISPW shares) Exercise Price subject to adjustment and expire five years after the closing of the merger on December 21, 2023, or earlier upon redemption or liquidation.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Options vest quarterly over 4 years.

The Reporting Person files this Amendment No. 1 to its original Form 4 dated 08/13/2025 to correctly identify the purchase of 7,000 Warrant AISPW shares, not Common shares.


/s/ Victor L. Cangelosi, pursuant to power of attorney


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Options vest quarterly over 4 years.

The Reporting Person files this Amendment No. 1 to its original Form 4 dated 08/12/2025 to correctly identify the purchase of 10,000 Warrant AISPW shares, not Common shares.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Options vest quarterly over 4 years.

The Reporting Person files this Amendment No. 1 to its original Form 4 dated 08/08/2025 to correctly identify the purchase of 26,000 Warrant AISPW shares, not Common shares.


MacKenzie Realty Capital Inc. Common Stock

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.75 to $4.91, inclusive. The reporting person undertakes to provide to MacKenzie Realty Capital, Inc. (MKZR), any security holder of MKZR, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 to this Form 4.

MacKenzie Real Estate Advisers, LP ("MREA") acquired shares of MacKenzie Realty Capital, Inc. ("MRC"). The filer owns an interest in MREA and therefore could be deemed to beneficially own the MRC shares acquired by MREA, but disclaims beneficial ownership of the securities referred to herein except to the extent of the filer's pecuniary interest in such securities.

MPF Successors, LP ("MPF") acquired shares of MacKenzie Realty Capital, Inc. ("MRC"). The filer owns an interest in MPF and therefore could be deemed to beneficially own the MRC shares acquired by MPF, but disclaims beneficial ownership of the securities referred to herein except to the extent of the filer's pecuniary interest in such securities.

/s/ Jeri Bluth, as attorney-in-fact for Angche Sherpa


Common Stock

1. Not applicable. Each Restricted Stock Unit represents the right to receive one share of the Issuer's common stock upon vesting.


/s/ Jeri Bluth, as attorney-in-fact for Christine Simpson


This transaction reported on this Form 4 was made pursuant to a 10b5-1 trading plan adopted by the reporting person as of March 28, 2025.

/s/ Sarah R. D'Amore, By Power of Attorney


/s/ Jeri Bluth, as attorney-in-fact for Glen Fuller


Scott J. Lynn, Attorney-in-Fact for Eric H. Bolton, Jr.


Represents performance-based restricted stock units ("PRSUs") awarded under the Issuer's 2018 Equity Incentive Plan. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.  The PRSUs vest in accordance with performance-based and service-based conditions.

Includes common stock owned and unvested restricted stock units.


The reported transaction represents an optional cash purchase of shares under the Company's DRIP.


/s/ Jeri Bluth, as attorney-in-fact for Charles E. Patterson II


Represents restricted stock units ("RSUs") granted on August 14, 2025. The RSUs will vest in 3 equal annual installments beginning August 14, 2026, and convert to shares of common stock of the Issuer on a 1-for-1 basis upon vesting.

/s/ Cristina Paradiso, Attorney-In-Fact for Surabhi Pokhriyal


/s/ Jeri Bluth, as attorney-in-fact for Robert Dixon


Common Stock


Common Stock

Amount includes 30.1294 shares acquired on June 30, 2025 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan.

Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.

Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.

The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.


Shares sold for general consumer purposes.


Represents 250,000 restricted stock of the issuer awarded to Mr. Blake under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.


This figure does not include 102,818 shares held directly by Mr. Stahl.

For each indirect account, Mr. Stahl disclaims beneficial ownership except to the extent of his pecuniary interest, if any.


Common Stock, par value $0.01 per share

Excludes 64 shares filer previously owned directly with his spouse, which were contributed to Teaghlach LLC on February 12, 2025.

Represents the average sales price of multiple individual transactions at prices between $1,300.00 and $1,300.90. Filer agrees to provide, upon request by the Commission staff, full information regarding the number of shares purchased or sold at each separate price.

Represents the average sales price of multiple individual transactions at prices between $1,301.16 and $1,301.97. Filer agrees to provide, upon request by the Commission staff, full information regarding the number of shares purchased or sold at each separate price.

Represents the average sales price of multiple individual transactions at prices between $1,302.59 and $1,303.11. Filer agrees to provide, upon request by the Commission staff, full information regarding the number of shares purchased or sold at each separate price.

The reported securities are held by SRB Investments LLC, a limited liability company of which the reporting person is the sole Operations Manager. The reporting person disclaims beneficial ownership of the MTD common stock held by SRB Investments LLC except to the extent of his pecuniary interest therein.

The reported securities are held by Teaghlach LLC, a limited liability company that the reporting person fully owns and controls with his spouse.

The options vested annually in two equal installments beginning on the first anniversary of the date of grant.


Class A Common Stock

Class A Common Stock

Class A Common Stock

Represents restricted stock units that vest in four equal annual installments beginning on July 22, 2026, subject to the reporting person's continued employment on the applicable vesting date.

These options will become 100% vested and exercisable on July 22, 2029, subject to the reporting person's continued employment on the applicable vesting date.


These Shares of the Issuer are owned directly by the UAW Chrysler Retirees Medical Benefits Plan, as established and maintained by the UAW Chrysler Retirees Employees' Beneficiary Association, an employee organization within the meaning of Section 3(4) of the Employee Retirement Income Security Act of 1974, as amended ("ERISA") under the UAW Retiree Medical Benefits Trust, organized as a 501(c)(9) Voluntary Employee Beneficiary Association (the "UAW RMBT").

These Shares of the Issuer are owned directly by the UAW Ford Retirees Medical Benefits Plan, as established and maintained by the UAW Ford Retirees Employees' Beneficiary Association, an employee organization within the meaning of Section 3(4) of ERISA under the UAW RMBT.

These Shares of the Issuer are owned directly by the UAW GM Retirees Medical Benefits Plan, as established and maintained by the UAW GM Retirees Employees' Beneficiary Association, an employee organization within the meaning of Section 3(4) of ERISA under the UAW RMBT.


This transaction reflects a charitable gift of 11,700 shares of Common Stock

Held by an irrevocable trust for benefit of his spouse and descendants (of which the reporting person's spouse, adult daughter and unrelated third person are trustees).


common stock

This option was granted on August 14, 2025 as an option for 4,092 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant.


common stock

This option was granted on August 14, 2025 as an option for 7,255 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant.


common stock

This option was granted on August 14, 2025 as an option for 3,720 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant.


common stock

This option was granted on August 14, 2025 as an option for 5,674 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant.


common stock

This option was granted on August 14, 2025 as an option for 5,534 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant.


common stock

This option was granted on August 14, 2025 as an option for 4,790 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant.


common stock

This option was granted on August 14, 2025 as an option for 4,278 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $3.60 per share. The options vest immediately upon grant.


common stock


Common Stock, par value $0.0001 per share


The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.


Represents an open market purchase of 2,000 shares at a price of $1.90 per share.

Represents an open market purchase of 2,300 shares at a price of $1.82 per share.

/s/ Veronica Gonzalez, as attorney-in-fact


Common Stock

Common Stock

The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.48 to $8.55. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

/s/ Alane P. Barnes, by power of attorney


The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.02 to $68.54.


The shares of common stock, par value $0.001 per share, of the Issuer ("Common Stock"), reported herein are held directly by Vector Capital VI, L.P. ("VCVI"). VCVI has delegated all voting and investment power over the securities in its portfolio to Vector Capital Management, L.P. ("VCM"), an investment adviser registered with the Securities and Exchange Commission (the "Commission").

VCM, together with Vector Capital, L.L.C. ("VCLLC"), its general partner, and Alexander R. Slusky ("Mr. Slusky"), the managing member of VCLLC and Chief Investment Officer of VCM, may be deemed to beneficially own the Common Stock held directly by VCVI. Each of VCM, VCLLC and Mr. Slusky disclaims beneficial ownership of the Common Stock held by VCVI, except to the extent of its or his pecuniary interest, if any, therein. The inclusion of the Common Stock in this report shall not be deemed an admission by such reporting person of beneficial ownership for any other purpose.

Reflects weighted average price. Range of prices were between $0.99 to $1.13. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Reflects weighted average price. Range of prices were between $0.98 to $1.01. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Reflects weighted average price. Range of prices were between $0.95 to $1.01. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.


/s/ David B. Weinstock, as attorney-in-fact


Common shares, par value $0.015

Common shares, par value $0.015

Restricted share units convert into common shares on a one-for-one basis.

The dividend equivalent rights vested in connection with the vesting of the restricted stock award(s) to which they relate.  Each dividend equivalent unit is the economic equivalent of one common share of Essent Group Ltd.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.67 to $62.78, inclusive. The reporting person undertakes to provide to Essent Group Ltd., any security holder of Essent Group Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.


The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.61 to $3.64. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The Amount of Securities Beneficially Owned Following Reported Transaction reflects a pro rata distribution in kind by the funds to their respective partners.

Dr. Leff does not own these shares in his individual capacity. These shares are owned directly by Luminari Capital, L.P. ("Luminari Capital"). The general partner of Luminari Capital is Luminari Capital Partners, LLC. Edgar Bronfman has an assignee interest in Luminari Capital Partners, LLC. Dr. Leff, as managing member of Luminari Capital Partners, LLC, may be deemed to have shared voting and investment power with respect to these securities. Each of Dr. Leff, Mr. Bronfman and Luminari Capital Partners, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein and the inclusion of these securities in this filing shall not be deemed an admission by any of them of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

Dr. Leff does not own these shares in his individual capacity. These shares are owned directly by Waverley Capital, L.P. ("Waverley Capital"). The general partner of Waverley Capital is Waverley Capital Partners, LLC. Dr. Leff and Mr. Bronfman, as managing members of Waverley Capital Partners, LLC, may be deemed to have shared voting and investment power with respect to these securities. Each of Dr. Leff, Mr. Bronfman and Waverley Capital Partners, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein and the inclusion of these securities in this filing shall not be deemed an admission by any of them of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

Dr. Leff does not own these shares in his individual capacity. These shares are owned directly by WL fuboTV, LP ("WL fuboTV"). The general partner of WL fuboTV is WL fuboTV GP, LLC. Dr. Leff and Mr. Bronfman, as managing members of WL fuboTV GP, LLC, may be deemed to have shared voting and investment power with respect to these shares. Each of Dr. Leff, Mr. Bronfman and WL fuboTV GP, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein and the inclusion of these securities in this filing shall not be deemed an admission by any of them of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.65 to $3.71. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects the receipt of 113,678 shares of common stock from Luminari Capital, Waverley Capital and WL fuboTV (each as defined above) in pro rata distributions in kind, and a transfer of 32,585 shares of common stock that are no longer reported as beneficially owned by the reporting person, which was exempt from reporting.


Mr. Bronfman does not own these shares in his individual capacity. These shares are owned directly by Luminari Capital, L.P. ("Luminari Capital"). The general partner of Luminari Capital is Luminari Capital Partners, LLC. Mr. Bronfman has an assignee interest in Luminari Capital Partners, LLC. Dr. Daniel V. Leff, as managing member of Luminari Capital Partners, LLC, may be deemed to have shared voting and investment power with respect to these securities. Each of Mr. Bronfman, Dr. Leff and Luminari Capital Partners, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein and the inclusion of these securities in this filing shall not be deemed an admission by any of them of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

Mr. Bronfman does not own these shares in his individual capacity. These shares are owned directly by Waverley Capital, L.P. ("Waverley Capital"). The general partner of Waverley Capital is Waverley Capital Partners, LLC. Mr. Bronfman and Dr. Daniel V. Leff, as managing members of Waverley Capital Partners, LLC, may be deemed to have shared voting and investment power with respect to these securities. Each of Mr. Bronfman, Dr. Leff and Waverley Capital Partners, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein and the inclusion of these securities in this filing shall not be deemed an admission by any of them of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

Mr. Bronfman does not own these shares in his individual capacity. These shares are owned directly by WL fuboTV, LP ("WL fuboTV"). The general partner of WL fuboTV is WL fuboTV GP, LLC. Mr. Bronfman and Dr. Daniel V. Leff, as managing members of WL fuboTV GP, LLC, may be deemed to have shared voting and investment power with respect to these shares. Each of Mr. Bronfman, Dr. Leff and WL fuboTV GP, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein and the inclusion of these securities in this filing shall not be deemed an admission by any of them of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

Includes 128,640 shares of common stock received from Luminari Capital, Waverley Capital and WL fuboTV (each as defined above) in pro rata distributions in kind.


The price quoted in column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $113.29 to $113.68, inclusive.  The Reporting Person undertakes to provide to Patrick Industries, Inc., any security holder of Patrick Industries, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the price range set forth in this footnote.

/s/ Andy L. Nemeth by Joel D. Duthie, attorney-in-fact


Common Stock, par value $0.001 per share

Shares held in Individual Retirement Accounts for the reporting person.


Common stock, $0.001 par value per share

The shares of common stock, par value $0.001 per share ("Common Stock") were issued to Riesling Power LLC ("Riesling Power") as prepaid rent pursuant to that certain lease agreement, dated as of October 12, 2025, among Lake Hawkeye LLC, a wholly owned subsidiary of TeraWulf Inc., Cayuga Operating Company LLC and Riesling Power.  The remaining 3,554,688  shares of Common Stock due as prepaid rent pursuant to the lease agreement will be issued to Riesling Power once TeraWulf Inc. receives stockholder approval to amend its certificate of incorporation to increase the number of its authorized shares of Common Stock.

By Riesling Power. The Paul B. Prager Revocable Trust ("Prager Revocable Trust") is the sole member of Riesling Power. The Reporting Person is the sole trustee of the Prager Revocable Trust and may be deemed to have the power to direct the voting and disposition of the Common Stock beneficially owned by the Prager Revocable Trust. Accordingly, pursuant to the regulations promulgated under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), Mr. Paul B. Prager may be deemed to be a beneficial owner of the shares of Common Stock held for the account of the Prager Revocable Trust.

By Beowulf E&D Holdings Inc. ("E&D Holdings"). The Reporting Person is the sole manager of E&D Holdings and, as a result, may be deemed to beneficially own the shares of Common Stock held by E&D Holdings. The Reporting Person disclaims beneficial ownership of such shares of Common Stock except to the extent of his pecuniary interest therein, and the inclusion of such shares of Common Stock in this report shall not be deemed an admission of beneficial ownership of all of the reported shares of Common Stock for purposes of Section 16 of the Exchange Act, or for any other purpose.

By Heorot Power Holdings LLC ("Heorot"). The Reporting Person is the sole manager of Heorot and, as a result, may be deemed to beneficially own the shares of Common Stock held by Heorot. The Reporting Person disclaims beneficial ownership of such shares of Common Stock except to the extent of his pecuniary interest therein, and the inclusion of such shares of Common Stock in this report shall not be deemed an admission of beneficial ownership of all of the reported shares of Common Stock for purposes of Section 16 of the Exchange Act, or for any other purpose.


On August 12, 2025 Mr. Cleveland sold 1,600 shares of Common Stock at a weighted average price of $345.63 per share. These shares were sold in multiple transactions at prices ranging from $345.02 to $346.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 12, 2025 Mr. Cleveland sold 1,646 shares of Common Stock at a weighted average price of $346.60 per share. These shares were sold in multiple transactions at prices ranging from $346.20 to $347.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 12, 2025 Mr. Cleveland sold 1,554 shares of Common Stock at a weighted average price of $347.64 per share. These shares were sold in multiple transactions at prices ranging from $347.23 to $348.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 12, 2025 Mr. Cleveland sold 4.803 shares of Common Stock at a weighted average price of $348.75 per share. These shares were sold in multiple transactions at prices ranging from $348.28 to $349.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 12, 2025 Mr. Cleveland sold 397 shares of Common Stock at a weighted average price of $349.76 per share. These shares were sold in multiple transactions at prices ranging from $349.35 to $350.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 12, 2025 Mr. Cleveland sold 48 shares of Common Stock at a weighted average price of $354.02 per share. These shares were sold in multiple transactions at prices ranging from $354.01 to $354.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 13, 2025 Mr. Cleveland sold 1,000 shares of Common Stock at a weighted average price of $345.62 per share. These shares were sold in multiple transactions at prices ranging from $345.16 to $346.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 13, 2025 Mr. Cleveland sold 1,000 shares of Common Stock at a weighted average price of $347.24 per share. These shares were sold in multiple transactions at prices ranging from $346.50 to $347.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 13, 2025 Mr. Cleveland sold 2,900 shares of Common Stock at a weighted average price of $348.35 per share. These shares were sold in multiple transactions at prices ranging from $348.00 to $348.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 13, 2025 Mr. Cleveland sold 96 shares of Common Stock at a weighted average price of $349.29 per share. These shares were sold in multiple transactions at prices ranging from $349.25 to $349.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 13, 2025 Mr. Cleveland sold 1,500 shares of Common Stock at a weighted average price of $356.00 per share. These shares were sold in multiple transactions at prices ranging from $356.00 to $356.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 14, 2025 Mr. Cleveland sold 300 shares of Common Stock at a weighted average price of $346.76 per share. These shares were sold in multiple transactions at prices ranging from $346.70 to $346.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on August 13, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Includes 171,225 shares issuable upon the settlement of RSUs granted to the Reporting Person.

/s/ Arthi Chakravarthy, Attorney-in-Fact for Kristina Truong


Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on August 14, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Includes 810,783 shares issuable upon the settlement of RSUs granted to the Reporting Person.

/s/ Arthi Chakravarthy, Attorney-in-Fact for Ajay Marathe


John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.

Certain of the securities of the Issuer referred to herein as beneficially owned by the Funds are the same securities reported separately in the Form 3 filed by Paulson & Co. on the date hereof.

JOHN PAULSON
 By:    /s/ John Paulson
 John Paulson


Common Stock

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Ondas Holdings Inc. (the "Company") common stock, par value $0.0001 per share.

These RSUs were granted in connection with the issuer's Compensation Committee's approval of the Amended and Restated Non-Employee Director Compensation Policy, attached as Exhibit 10.4 of the issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.

1,561 RSUs vest during the third quarter of 2025, 2,817 RSUs vest during the fourth quarter of 2025, 2,816 RSUs vesting during the first quarter of 2026 and 2,817 RSUs vest in each of the second, third and fourth quarters of 2026


Common Stock

The options were granted pursuant to the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan. The options shall vest and become exercisable in five equal tranches on the last date of each fiscal year, with the first vesting date being December 31, 2024. The options have a maximum term of 10 years from the date of grant.

This Form 4 is being filed late due to an inadvertent administrative error.

All information has been retroactively adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025.


The number of shares has been adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025.


On August 12, 2025 (the "Effective Time"), Mist Holding Co., a Delaware corporation and the parent company of Hayes Management Consulting LLC d/b/a MDaudit ("Parent"), completed the previously announced acquisition of the Issuer, pursuant to the Agreement and Plan of Merger, dated as of May 29, 2025 (the "Merger Agreement"), by and among the Issuer, Parent and MD BE Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation (the "Surviving Corporation") and becoming a wholly owned subsidiary of Parent (the "Merger"). The foregoing description of the Merger does not purport to be complete and is subject to and qualified in its entirety by the full Merger Agreement, which is included as Exhibit 2.1* of the Issuer's Form 8-K filed on August 13, 2025 (the "Form 8-K"), which is incorporated by reference.

Pursuant to the Merger Agreement, at the Effective Time, each share of common stock, par value $0.01 per share, of the Issuer (each, a "Share") issued and outstanding as of immediately prior to the Effective Time (other than certain Shares as specified in the Form 8-K which do not include any Shares previously reported herein), was automatically cancelled and converted into the right to receive $5.34 per Share in cash, without interest (the "Merger Consideration").

Represented a grant of Shares of restricted stock that was held for the benefit of the investors of Herbert Discovery Fund, LP (the "Fund") and may have previously been deemed to be beneficially owned by Kenan Lucas, the managing director and portfolio manager of the general partner of the Fund. Pursuant to the Merger Agreement, at the Effective Time, each restricted stock award corresponding to Shares granted under the Issuer's equity plans (each, a "Issuer Restricted Share") that was outstanding and unvested as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of Shares corresponding to such Issuer Restricted Shares immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration, less applicable withholding taxes.

These Shares reflect a 15-for-1 reverse stock split effective October 4, 2024.

The Shares were held in the account of the Fund and may have previously been deemed to be beneficially owned by Kenan Lucas, the managing director and portfolio manager of the general partner of the Fund. The cash proceeds attributable to the securities held in the account of the Fund have been paid to the Fund pursuant to the terms of the Merger Agreement.

The cash proceeds attributable to the Shares of restricted stock were paid to Harbert Fund Advisors, Inc., the investment adviser to the Fund for the benefit of the Fund, pursuant to the terms of the Merger Agreement.

The Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.


Exhibit List: Exhibit 24 - Limited Power of Attorney

/s/ Martin Garmendia as Attorney in Fact for JUDITH ANN FEDDER


Common Stock

Represents an award of restricted stock units granted under the AerSale Corporation 2020 Equity Incentive Plan, as amended (the "Plan"), that will vest in one-third increments on each of June 7, 2026, June 7, 2027, and June 7, 2028.

Represents stock options granted under the Plan that will vest in one-third increments on each of June 7, 2026, June 7, 2027, and June 7, 2028.

SVP, General Counsel & Corporate Secretary


Represents fully vested restricted stock units.

The shares are held by the Lawrence G. and Janice C. Finch Revocable Trust, of which the reporting person is trustee.

/s/ Cesare Suardi, Attorney-in-Fact for Lawrence G. Finch


Common Stock, par value $0.0001 per share ("Common Stock")

Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Includes 294,212 shares of unvested restricted stock units.

The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $18.11 to $18.13, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.185, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

Represents shares of Common Stock sold by the Reporting Person in connection with the exercise of 40,831 stock options.

The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $18.475 to $18.540, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

The option has vested and is exercisable as of the date hereof.

This option has vested and is exercisable as of the date hereof as to 40,831 shares of Common Stock and the remaining portion of the option vests in monthly installments of 2,083 or 2,084 shares of Common Stock on the 1st of each month through May 1, 2027.


Includes 812,837 shares of unvested restricted stock units.

The option has vested and is exercisable as of the date hereof as to 967,407 shares of Common Stock and the remaining portion of the option vests on August 20, 2025 as to 31,277 shares of Common Stock.

This option has vested and is exercisable as of the grant date as to all 120,826 shares of Common Stock.


Common Stock, par value $0.0001

This Form 4 relates to a bona fide gift of publicly-traded warrants (the "Warrants") previously distributed to the Rodgers Massey Revocable Living Trust dtd 4/4/11 (the Trust) for which the Reporting Person is a trustee and has voting and dispositive power over the Warrants. The Warrants were distributed by the Issuer on July 21, 2025 at no cost to the Reporting Person, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement dated July 21, 2025 between the Issuer and Computershare Trust Company N.A., as warrant agent (the "Warrant Agreement").

Represents a bona fide gift of 500,000 Warrants from the Trust to a donor advised fund.

The Warrants will expire and cease to be exercisable at 5:00 p.m. New York City time on October 1, 2026 (the Expiration Date). The Expiration Date is subject to automatic acceleration upon satisfaction of the early expiration price condition (as defined in the Warrant Agreement) and subject to the other terms of the Warrant Agreement.

The remaining Warrants are held by the Trust for which the Reporting Person is a trustee and has voting and dispositive power over the Warrants.

/s/ Arthi Chakravarthy, Attorney-in-Fact for Thurman J. Rodgers


Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the "Company"), Concentra Biosciences, LLC, a Delaware limited liability company ("Parent"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), on August 14, 2025, Merger Sub merged with and into the Company (the "Merger"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a "CVR") subject to the terms and conditions of a Contingent Value Rights Agreement.


Common Stock

These stock options were fully vested and exercisable.

Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.


The prices reported in Column 4 reflect a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.385 to $25.39. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

/s/ Christopher Kevane, Attorney-in-Fact for Robert T. DeVincenzi


Common Stock

Common Stock

These RSUs vest 50% on August 13, 2025 and 50% on December 3, 2025

These RSUs were previously reported on Form 4, Table 1 as Common Stock with the vesting schedule provided in a footnote and are now being transferred from Table 1 to Table 2 on this Form 4 for ease of form preparation.


Common Stock

Common Stock


Common Stock

Common Stock

Common Stock

This is a weighted average of prices for all sales made on August 14, 2025 ranging from $9.3979 to $9.6601. Upon request, the Reporting Person will provide to the SEC, the Issuer, or any security holder of the Issuer full information regarding the number of shares sold at each separate price.

These RSUs vest 50% on September 30, 2025 and 50% on September 30, 2026.

These RSUs vest in equal installments on August 13, 2025, December 3, 2025, February 13, 2026, May 13, 2026, August 13, 2026, December 3, 2026, February 12, 2027, May 13, 2027, August 13, 2027 and December 3, 2027.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock


Common Stock

Common Stock

Common Stock

These RSUs vest on September 12, 2025.


Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.

The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $13.35 to $13.58 per share. Upon request by the Commission staff, the Issuer, or a
security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Includes 128,405 Unvested RSUs.

Includes 975 shares acquired under the ESPP Purchase on June 2, 2025.

The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.


The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $13.34 to $13.58 per share. Upon request by the Commission staff, the Issuer, or a
security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Includes 128,405 Unvested RSUs.

The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted December 11, 2024.

The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.


Common Stock

Common Stock

Represents restricted stock units (RSUs) granted to the Reporting Person. One third of the RSUs shall vest on each of August 12, 2026, August 12, 2027 and August 12, 2028, subject to the Reporting Person continuing to provide services through each such date and contingent upon approval of the grant at the Issuer's 2026 Annual Meeting of Stockholders.

One third of the shares subject to the option shall vest on August 12, 2026, with the remainder vesting in equal installments each successive month thereafter for a period of 24 months, subject to the Reporting Person continuing to provide services through each such date.


Common Stock

Common Stock

Represents restricted stock units (RSUs) granted to the Reporting Person. One third of the RSUs shall vest on February 12, 2026, with the remainder vesting in equal installments in each successive quarter thereafter for a period of 12 months, subject to the Reporting Person continuing to provide services through each such date and contingent upon approval of the grant at the Issuer's 2026 Annual Meeting of Stockholders.

One half of the shares subject to the option shall vest on February 12, 2026, with the remainder vesting in equal installments in each successive month thereafter for a period of 12 months, subject to
the Reporting Person continuing to provide services through each such date; provided that one half of the shares subject to the option shall vest immediately upon achievement of certain performance-based
milestones prior to February 12, 2026.


Transfer to Family Trust Account.

Sean K. Clark, Attorney-in-Fact for Peggy Y. Fowler


Includes shares purchased through the Under Armour, Inc. Employee Stock Purchase Plan.

No Class A Common Stock (UAA) is beneficially owned.

/s/ Mehri F. Shadman, Attorney in- Fact for Eric J. Aumen


This transaction was executed in multiple trades at prices ranging from $4.88 to $4.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/ Mehri F. Shadman, Attorney-in-Fact for Dawn N. Fitzpatrick


Common Stock, par value $2 per share ("Common Stock")

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $5.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The shares of Common Stock reported herein are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser; and (b) a separate account investment advisory client of CCM (the "Separate Account").

Christopher S. Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC. Each of Shackelton, Gray, CCP, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.27 to $5.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.00 to $5.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Following the transactions reported herein, CCP directly owned 10,657,337 shares of Common Stock and the Separate Account directly owned 2,443,470 shares of Common Stock.


This transaction was executed in multiple trades at prices ranging from $37.00 to $37.265. The price reported above reflects the weighted average price.

Zi Yao Lim, Attorney-in-Fact for Wong Nelson MunPun


The reported sale was made pursuant to a pre-arranged program for selling shares of Class A Common Stock adopted on May 14, 2025 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.


Reflects the weighted average purchase price. The highest price at which shares were purchased was $3.735 and the lowest price at which shares were purchased was $3.53. The reporting person has reported on a single line all transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Reflects the weighted average purchase price. The highest price at which shares were purchased was $3.945 and the lowest price at which shares were purchased was $3.81. The reporting person has reported on a single line all transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Reflects the weighted average purchase price. The highest price at which shares were purchased was $3.915 and the lowest price at which shares were purchased was $3.835. The reporting person has reported on a single line all transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Securities owned directly by Stoney Lonesome HF LP ("Stoney Lonesome"). Mr. Coghill, as the President and sole shareholder of CDC Financial, Inc. ("CDC Financial"), the managing member of the general partner of Stoney Lonesome, may be deemed to beneficially own the securities owned directly by Stoney Lonesome.

Securities owned directly by The Drake Helix Holdings, LLC ("Drake Helix"). Mr. Coghill, as the President and sole shareholder of CDC Financial, the managing member of Drake Helix, may be deemed to beneficially own the securities owned directly by Drake Helix.

Mr. Coghill disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that Mr. Coghill is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.


Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock units.

/s/ Candace Jackson, as Attorney-in-Fact


Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

Includes restricted stock units and dividend equivalent units.

Power of Attorney attached as Exhibit 24.


On August 12, 2025 Mr. Cleveland sold 1,600 shares of Common Stock at a weighted average price of $345.63 per share. These shares were sold in multiple transactions at prices ranging from $345.02 to $346.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 12, 2025 Mr. Cleveland sold 1,646 shares of Common Stock at a weighted average price of $346.60 per share. These shares were sold in multiple transactions at prices ranging from $346.20 to $347.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 12, 2025 Mr. Cleveland sold 1,554 shares of Common Stock at a weighted average price of $347.64 per share. These shares were sold in multiple transactions at prices ranging from $347.23 to $348.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 12, 2025 Mr. Cleveland sold 4.803 shares of Common Stock at a weighted average price of $348.75 per share. These shares were sold in multiple transactions at prices ranging from $348.28 to $349.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 12, 2025 Mr. Cleveland sold 397 shares of Common Stock at a weighted average price of $349.76 per share. These shares were sold in multiple transactions at prices ranging from $349.35 to $350.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 12, 2025 Mr. Cleveland sold 48 shares of Common Stock at a weighted average price of $354.02 per share. These shares were sold in multiple transactions at prices ranging from $354.01 to $354.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 13, 2025 Mr. Cleveland sold 1,000 shares of Common Stock at a weighted average price of $345.62 per share. These shares were sold in multiple transactions at prices ranging from $345.16 to $346.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 13, 2025 Mr. Cleveland sold 1,000 shares of Common Stock at a weighted average price of $347.24 per share. These shares were sold in multiple transactions at prices ranging from $346.50 to $347.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 13, 2025 Mr. Cleveland sold 2,900 shares of Common Stock at a weighted average price of $348.35 per share. These shares were sold in multiple transactions at prices ranging from $348.00 to $348.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 13, 2025 Mr. Cleveland sold 96 shares of Common Stock at a weighted average price of $349.29 per share. These shares were sold in multiple transactions at prices ranging from $349.25 to $349.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 13, 2025 Mr. Cleveland sold 1,500 shares of Common Stock at a weighted average price of $356.00 per share. These shares were sold in multiple transactions at prices ranging from $356.00 to $356.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

On August 14, 2025 Mr. Cleveland sold 300 shares of Common Stock at a weighted average price of $346.76 per share. These shares were sold in multiple transactions at prices ranging from $346.70 to $346.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Common Stock

Common Stock

Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026.

1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date.

John R. Moore, by POA from Robert Blaustein


Common Stock

Common Stock

Common Stock

Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person

The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $13.36 to $13.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025.


Common Stock

Common Stock

Common Stock

/s/ John R Moore Attorney-in-Fact for Behrad Derakhshan


Common Stock

Common Stock

Common Stock

Includes 795 shares purchased on May 15, 2025 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.

/s/ John R. Moore Attorney-in-Fact for R. Michael Carruthers


Common Stock

Common Stock

Common Stock

Includes 1,005 shares purchased on May 15, 2025 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.

/s/ John R. Moore, Attorney-in-Fact for Russell Alan J


Common Stock

Common Stock

Common Stock

In previous Forms 4, a duplicate 26,410 shares held indirectly were reported in error.

/s/John R. Moore Attorney-in-Fact for Kevin Koch


Common Stock

Common Stock

Common Stock

Includes 854 shares purchased on May 15, 2025 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.

John R. Moore Attorney-in-Fact for Donovan Joanne M.


Common Stock

Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents the contingent right to receive one share of Common Stock of the Issuer upon vesting of the RSU.

The RSUs and the Stock Options were granted to the Reporting Person as a bonus and vested immediately (the "Bonus"). The Bonus was approved by the Issuer's Board of Directors.

The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

These shares were sold in multiple transactions at prices ranging from $18.84520 to $18.85230. The price reported above reflects the weighted average sale price. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price.


This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Weighted average price. These shares were sold in multiple transactions at prices ranging from $19.61 to $19.96 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.


Lee Michael Stewart

ONE LETTERMAN DR., BLDG. D, SUITE D3-300

On August 14, 2025, pursuant to the terms of the Agreement and Plan of Merger, dated as of July 1, 2025, among the Issuer, Concentra Biosciences, LLC, a Delaware limited liability company ("Parent"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub completed a tender offer to purchase all outstanding shares of the Issuer's Common Stock and Non-Voting Common Stock in exchange for (a) a price per share of $1.247 in cash (the "Offer Price"), subject to applicable tax withholding and without interest, plus (b) one contingent value right ("CVR") per share subject to the terms and conditions of a Contingent Value Rights Agreement . The tender offer expired one minute following 11:59 p.m., Eastern Time, on August 13, 2025 (the "Offer Closing").

The reported securities were granted to Michael Lee, a managing director of Redmile Group, LLC ("Redmile"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee held these securities as a nominee on behalf, and for the sole benefit, of Redmile and assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Lee disclaimed beneficial ownership of the reported securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee was the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

The securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the securities except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Mr. Lee, a managing director of Redmile, resigned as a member of the board of directors of the Issuer immediately prior to the effective date and time of the merger between Issuer and Merger Sub.


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.54, inclusive. The reporting person undertakes to provide to Full House Resorts, Inc., any stockholder of Full House Resorts, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.


This transaction was executed in multiple trades at prices ranging from $84.43 to $83.84 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected

By Marianne Boyd Johnson as Trustee of the Marianne Boyd Johnson Gaming Properties Trust.

By WSB-BYD, LLC, of which the reporting person is the Manager.

By Marianne Boyd Johnson as Trustee of the Justin Boyd Education Trust Dated 11/1/99.

By the Johnson Children's Trust Dated 6/24/96, Bruno Mark, Trustee.

By BG-00 Limited Partnership, of which the Marianne Boyd Gaming Properties Trust, of which the reporting person is the trustee, settlor and beneficiary, is the general partner thereof.

By BG-SUB, LLC of which Marianne Boyd Johnson is the managing member thereof.

By BYD-SST LLC, of which Marianne Boyd Johnson is the managing member thereof. .

*The reporting person expressly disclaims beneficial ownership of any securities of the Issuer except for those securities that are owned directly by the Reporting Person or to the extent of the Reporting Person's pecuniary interest in a trust or other entity which owns such securities.

/s/ Uri Clinton, attorney-in-fact for Marianne Boyd Johnson


Share amount is based on the closing price of the Issuer's common stock on the grant date, August 4, 2025 (amount in the initial filing was inadvertently determined based on the July 31, 2025 closing price).

Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number
of common shares of the Issuer: (i) 14,926 RSUs scheduled to vest on July 3, 2026; (ii)
29,632 RSUs scheduled to vest in two equal annual installments on July 1, 2026 and 2027; and (iii)
8,933 RSUs scheduled to vest in three equal installments on August 4, 2026, 2027 and 2028.

/s/ Audrey Lee, by power of atty., for Scott Macdonald


Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number
of common shares of the Issuer: (i) 4,010 RSUs scheduled to vest on July 3, 2026; (ii) 9,086
RSUs scheduled to vest in two equal annual installments on July 1, 2026 and 2027; and (iii) 4,647 RSUs scheduled to vest in three equal annual installments on August 4, 2026, 2027 and 2028.

/s/ Audrey Lee, by power of atty., for Jason Wyrick


Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number
of common shares of the Issuer: (i) 7,071 RSUs scheduled to vest on July 3, 2026; (ii)
13,770 RSUs scheduled to vest in two equal annual installments on July 1, 2026 and 2027; and (iii)
6,162 RSUs scheduled to vest in three equal installments on August 4, 2026, 2027 and 2028.


Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number
of common shares of the Issuer: (i) 21,843 RSUs scheduled to vest on July 3, 2026; (ii)
41,298 RSUs scheduled to vest in two equal annual installments on July 1, 2026 and 2027; and (iii) 13,457 RSUs scheduled to vest in three equal installments on August 4, 2026, 2027 and 2028.

/s/ Audrey Lee, by power of atty., for Alison Hoffman


Class A Common Stock

Shares of Class V-1 Common Stock of the Issuer have no economic rights and each share of Class V-1 Common Stock entitles its holder to 1 vote per share.

The term "Symbotic Holdings Units" is used herein to represent limited liability company units of Symbotic Holdings and an equal number of paired shares of Class V-1 Common Stock of the Issuer, which, pursuant to the limited liability company agreement of Symbotic Holdings, are together redeemable by the holder on a one-for-one basis for a share of Class A Common Stock of the Issuer, subject to conversion rate adjustments for stock splits, stock dividends, reclassification and other similar transactions, and in accordance with other terms and conditions set forth in Symbotic Holdings' Second Amended and Restated Limited Liability Company Agreement, dated as of June 7, 2022. Upon redemption, the Issuer will cancel the Symbotic Holdings Units and cancel and retire for no consideration the redeemed shares of Class V-1 Common Stock.

On August 12, 2025, each of the Audrey Exempt Trust, u/a, the Jessica Exempt Trust, u/a, and the Paige Exempt Trust, u/a,  sold 30,000 shares of Class A Common Stock (the "Stock Sale"),  In connection with the Stock Sale, effective August 12, 2025, each of the Audrey Exempt Trust, u/a, the Jessica Exempt Trust, u/a, and the Paige Exempt Trust, u/a, redeemed 30,000 Symbotic Holdings Units in exchange for an equal number of shares of Class A Common Stock (the "Stock Redemption"). In connection with the Stock Redemption, Symbotic Holdings canceled the Symbotic Holdings Units, and the Issuer canceled and retired for no consideration the redeemed 90,000 shares of Class V-1 Common Stock.

Rollin Ford may be considered to have an indirect pecuniary interest in the shares of Class V-1 common stock held by the Audrey Exempt Trust, u/a,  by the Jessica Exempt Trust, u/a, and by the Paige Exempt Trust, u/a (collectively the "Trust V-1 Shares"), each of which has Mr. Ford's spouse as a Trustee and to which members of Mr. Ford's immediate family have a pecuniary interest. Mr. Ford does not have voting or investment control over the Trust Shares and disclaims beneficial ownership of the Trust V-1 Shares except to the extent that Mr. Ford may be considered to have an indirect pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Trust V-1 Shares for purposes of Section 16 or for any other purpose.

Rollin Ford may be considered to have an indirect pecuniary interest in the Class A common stock held by the Audrey Exempt Trust, u/a, the Class A common stock held by the Jessica Exempt Trust, u/a, and Class A common stock held by the Paige Exempt Trust, u/a (collectively the "Trust Common Stock"), each of which has Mr. Ford's spouse as a Trustee and to which members of Mr. Ford's immediate family have a pecuniary interest. Rollin Ford does not have voting or investment control over the Trust Shares and disclaims beneficial ownership of the Trust Shares except to the extent that Mr. Ford may be considered to have an indirect pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Trust Common Stock for purposes of Section 16 or for any other purpose.

In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $51.25  to $52.12, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Rollin Ford may be considered to have an indirect pecuniary interest in shares of Class A Common Stock held directly by the RLF 2020 Gift Trust, in which Mr. Ford's wife acts as trustee and to which Mr. Ford's immediate family have a pecuniary interest. Mr. Ford does not have voting or investment control over the shares and disclaims beneficial ownership of the shares held by the RLF 2020 Gift Trust except to the extent that Mr. Ford may be considered to have an indirect pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares held by the RLF 2020 Gift Trust for purposes of Section 16 or for any other purpose.

Rollin Ford may be considered to have an indirect pecuniary interest in the Symbotic Holdings Units held by the Audrey Exempt Trust, u/a, by the Jessica Exempt Trust, u/a, and by the Paige Exempt Trust, u/a (collectively the "Trust Units"), each of which has Mr. Ford's spouse as a Trustee and to which members of Mr. Ford's immediate family have a pecuniary interest. Mr. Ford does not have voting or investment control over the Trust Units and disclaims beneficial ownership of the Trust Units except to the extent that Mr. Ford may be considered to have an indirect pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Trust Units for purposes of Section 16 or for any other purpose.

/s/ Corey Dufresne, as Attorney-in-Fact for Reporting Person


This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on May 13, 2025.

This transaction was executed in multiple trades at prices ranging from $181.77 to $181.78. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $183.26 to $184.22. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $184.52 to $185.46. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $185.61 to $186.60. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $186.61 to $187.49. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $187.73 to $187.74. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $185.00 to $185.96. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $186.07 to $186.98. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $187.11 to $187.84. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $188.51 to $189.20. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction was executed in multiple trades at prices ranging from $189.67 to $190.25. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


These shares were purchased in multiple transactions on August 13, 2025 at prices ranging from $22.66 to $22.93 per share. The price reported reflects the weighted average purchase prices for the transactions. The reporting person undertakes to provide, upon request by SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

/s/ David C. Kuo, attorney in fact for William H. Yeh


These shares were purchased through 401(k) in multiple transactions on August 12, 2025 at prices ranging from $22.80 to $23.40 per share. The price reported reflects the weighted average purchase prices for the transactions. The reporting person undertakes to provide, upon request by SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

These shares were purchased in multiple transactions on August 13, 2025 at prices ranging from $22.13 to $22.99 per share. The price reported reflects the weighted average purchase prices for the transactions. The reporting person undertakes to provide, upon request by SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

These shares were purchased through 401(k) in multiple transaction on August 13, 2025 at prices ranging from $22.15 to $23.27 per share. The price reported reflects the weighted average purchase prices for the transactions. The reporting person undertakes to provide, upon request by SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

/s/ David C. Kuo, attorney in fact for Chih-Hsiang (Thompson) Lin


The price shown in Column 4 is a weighted average price. The price range is $7.2399 to $7.8000. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares transacted at each separate price.

The price shown in Column 4 is a weighted average price. The price range is $8.8889 to $9.2892. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares transacted at each separate price.

The price shown in Column 4 is a weighted average price. The price range is $8.7100 to $9.0900. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares transacted at each separate price.

The shares are owned directly by North Sound Trading, LP, a Delaware partnership ("North Sound Trading"). Mr. Miller is the sole shareholder of North Sound Management, Inc., a Delaware corporation ("North Sound Management"), which in turn is the general partner of North Sound Trading. Mr. Miller and North Sound Management may be deemed to indirectly own the shares directly owned by North Sound Trading. Each of North Sound Trading and North Sound Management may be deemed a director by deputization by virtue of their relationship with Mr. Miller, a director of the Issuer.


These shares were purchased in multiple transactions on August 13, 2025, at prices ranging from $22.50 to $23.20 per share. The price reported reflects the weighted average purchase price for the transactions. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Held directly by Yuh-Mei Chung, the spouse of Min-Chu (Mike) Chen. Mr. Chen disclaims beneficial ownership of all securities that may be deemed to be beneficially owned by his spouse, except to the extent of any indirect pecuniary interest therein.

/s/ David C. Kuo, attorney in fact for Min-Chu (Mike) Chen


The shares were sold in multiple transactions on August 13, 2025 at actual sale prices ranging from $22.58 to $22.81 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold during each transaction.

*** Senior Vice President and North America General Manager

/s/ David C. Kuo, attorney in fact for Hung-Lun (Fred) Chang


The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $111.75 to $112.435 inclusive.  The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $112.48 to $113.435, inclusive.  The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

By: Paula Darbyshire, Attorney-in-Fact  For: Vivek Jain


Knight-Swift Transportation Holdings Inc.

The price reported is a weighted average price.  The shares were sold in multiple transactions at a price ranging from $42.3001 to $42.7000, inclusive.  The reporting person undertakes to provide KNX, any security holder of KNX, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to Form 4.